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Abstract: Guanine quadruplexes (GQs) are compact four-
stranded DNA structures that play a key role in the control of
a variety of biological processes, including gene transcription.
Bulky ruthenium complexes featuring a bipyridine, a terpyr-
idine, and one exchangeable ligand ([Ru(terpy)(bpy)X]n+) are
able to metalate exposed guanines present in the GQ of the c-
MYC promoter region that are not involved in quadruplex
base pairing. qRT-PCR and western-blot experiments indicated
that the complexes promote a remarkable increase in the
expression of this oncogene. We also show that exchangeable
thioether ligands (X = RSR’, Met) allow regulation of the
metalating activity of the complex with visible light.
There is great interest in the development of metal-based
DNA binders that show improved selectivity and reduced
toxicity relative to cis-platinum.[1] Ruthenium complexes are
promising alternatives owing to their kinetic stability and rich
photochemistry and redox properties.[2] In addition to non-
covalent recognition of double-stranded DNA (dsDNA),
several ruthenium complexes that form covalent DNA
adducts, especially through reaction with the N7 of guanines,
have also been described.[3] While most of these complexes
bind dsDNA, the functional relevance of G-quadruplexes
(GQs)[4, 5] calls for the development of probes capable of
targeting these structures.[6] To our knowledge, there is only
one precedent for the covalent metalation of a GQ structure
with a ruthenium complex, and the reaction presents low
selectivity.[7]
Herein, we demonstrate that coordination complexes of
the type [Ru(terpy)(bpy)X]n+ (X = Cl, RSR’, Met) can
selectively metalate unpaired guanines present in parallel
GQs, a reaction that is enhanced upon irradiation. Impor-
tantly, we have found that this selective metalation increases
the expression of the oncogene c-MYC, apparently by
disrupting the parallel GQ structure present in its promoter
region.
Our work was conceived after learning that while most
DNA-metalating ruthenium agents are cytotoxic, the com-
plex [Ru(terpy)(bpy)Cl]+ (1) exhibits very low toxicity.[8] We
reasoned that the bulky and relatively hydrophobic nature of
this sort of complexes could offer excellent opportunities for
the selective modification of accessible guanines, thereby
promoting specific biological responses with reduced toxicity.
We first studied the ability of chloro complex 1 to
metalate guanosine monophosphate (GMP). Mixing complex
1 with 3 equiv of GMP in phosphate buffer (pH 7.5), led to
the partial formation of the aquo complex [Ru(terpy)-
(bpy)H2O]
+2 (2 ; over 50% after 30 min at RT), while the
guanosine remained essentially unreacted (Figure 1B,
trace b). Further incubation for 2 h afforded the metalated
product 3 and the aquo derivative 2 (Figure 1A), with total
consumption of the starting chloride (Figure 1B, trace d).
Figure 1. A) GMP metalation reaction with [Ru(terpy)(bpy)Cl]PF6 ([Ru]-
Cl, 1) and formation of the aquo derivative 2. B) HPLC of the reaction
of 1 (250 mm) and GMP (750 mm) in 10 mm phosphate buffer pH 7.5,
100 mm NaCl: in the dark at t = 0 (trace a); after 30 min in the dark
(trace b); initial mixture after 30 min of irradiation at 455 nm (trace c);
and initial mixture after 2 h in the dark (trace d). The injection peak is
labeled with an asterisk. C) Signal in the MS spectrum corresponding
to the monoadduct 3.
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Interestingly, irradiation of the initial mixture for 30 min (l =
455 nm) led exclusively to the formation of the monoadduct 3
(approximate conversion of 80% based on the disappearance
of GMP; Figure 1B, trace c and Figure S5 in the Supporting
Information). Importantly, the reaction is fully orthogonal, so
competitive control experiments in the presence of excess
adenosine monophosphate (AMP), cytidine monophosphate
(CMP), and thymidine monophosphate (TMP; Figure S6), as
well as lysine or even cysteine (Figure S7), led exclusively to
the formation of the GMP derivative. Moreover, experiments
with double-stranded oligonucleotides (dsDNAs) presenting
different arrangements of guanines revealed modest reactiv-
ity, but only with those featuring terminal guanines (Table S1,
and Figures S10–S13 in the Supporting Information). This
selectivity most likely stems from the bulkiness of complex 1,
which cannot reach the sterically hindered nucleophilic N7
site in paired, internal guanines.[9]
Remarkably, irradiation of a mixture of the parallel c-
MYC quadruplex d[TTGAG3TG3TAG3TG3TA3]
[10] (10 mm)
with 5 equiv of 1 in 10 mm phosphate buffer (pH 7.5) and
100 mm KCl led to the clean formation of a product with
a mass corresponding to a monoadduct derivative (Fig-
ure 2A, trace C, peak at 22 min, MYC-[Ru], 81% conver-
sion). We also observed reaction in the absence of light
(approx. 41 % conversion after 30 min at RT, Figure 2A,
trace b). Importantly, MS analysis of the bovine spleen
phosphodiesterase (BSP) digestion of the ruthenated oligo-
nucleotides lead to identification of the first guanine of the
sequence (5’-TTGA…, Figure 2 C) as the metalation site
(Figure S24).[11] No reaction was observed under the same
conditions with a mutated c-MYC GQ containing a C instead
of a G in position 3 (MYCm, d[TTCAG3TG3TAG3TG3TA3];
Figure S18).
The chemoselectivity of the reaction can be rationalized
by considering the secondary structure of the c-MYC GQ
(Figure 3), which shows that G3 is exposed to the solvent and
does not participate in the formation of the G-quartets. As
a consequence, it has a highly accessible N7 nucleophile that
can react with the bulky ruthenium complex. Importantly,
circular dichroism experiments revealed that the GQ secon-
dary structure is disrupted in the ruthenium adduct MYC-
[Ru] (Figure S3, right). Control experiments with other
related parallel quadruplex such as c-KIT1, which also
presents non-stacked guanines, revealed a similar reactivity
pattern. Mass spectrometry shows that the promoter is
modified by the ruthenium complex at the expected positions
(Figures S21 and S22), although curiously, in this case, CD
analysis revealed that the quadruplex remained mostly intact
(Figure S4).[12]
With the above molecular information, we explored
whether Ru complex 1 could affect the expression of the
oncogene c-MYC, since this oncogene is involved in many
important cellular processes.[13] This was analyzed by real-
time quantitative reverse transcription PCR (qRT-PCR) in
HeLa and Vero cells (Figure 4 and Figure S26, respectively),
using porphyrin TMPyP4, a GQ binder that is known to
repress the expression of c-MYC,[14] as a control. As shown in
Figure 4, HeLa cells treated with 1 (100 mm) in DulbeccoQs
modified EagleQs medium (DMEM) presented a modest but
significant increase in the transcription of c-MYC compared
to untreated cells (80 % at 16 h and 200% at 48 h).[15] As
expected, treatment with TMPyP4 led to a 60% decrease in
the cellular levels of c-MYC mRNA after 48 h.
We also analyzed the expression of c-MYC protein by
western blot. In agreement with the qRT-PCR results, treat-
ment of cells with 100 mm of 1, led to a noticeable increase in
the levels of c-MYC protein (Figure 4, averaged 40%
Figure 3. Structure of the GQ of c-MYC (PDB ID: 1XAV), highlighting
the exposed G3 and the metalation selectivity. The large spheres in the
quadruplex structure represent potassium ions.
Figure 2. A) HPLC traces of a mixture of the GQ of c-MYC (MYC,
10 mm) and 1 (5 equiv) in 10 mm phosphate buffer pH 7.5, 100 mm
KCl, at RT: in the dark at t = 0 (trace a); after 30 min in the dark
(trace b), initial mixture after irradiation for 30 min at 455 nm (trace c).
B) MS of the metalated product (MYC-[Ru]) showing the peaks
corresponding to the complex (m/z = 8089) and the demetalated
fragment (m/z =7600). C) MS of the products after BSP digestion of
MYC-[Ru] showing the peaks corresponding to the digested complex
(m/z =7489) and non-metalated digested product (m/z =7000) result-
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increase). These data confirm that, in contrast to most
quadruplex targeting agents, complex 1 promotes an increase
instead of a decrease in the level of gene expression, thereby
acting as a transcriptional activator.[16] ICP-MS measurements
of isolated nuclei and chromatin obtained after treatment
with complex 1 confirmed the presence of relatively signifi-
cant amounts of ruthenium, which is consistent with efficient
cellular uptake and nuclear delivery of the complex
(Tables S2 and S3). In agreement with the early studies,[8]
cell viability assays confirmed that 1 is essentially non-
cytotoxic (Figure S27).
While the above data indicate that 1 is capable of altering
the expression of c-MYC, the development of derivatives that
could be activated by using external irradiation would be
highly attractive.[17] Towards this aim, we prepared complexes
4 and 5, which feature a thioether ligand (Figure 5) and are
kinetically stable but undergo rapid ligand exchange upon
irradiation with visible light.[18] In contrast to the chloride
complex 1, in vitro experiments with the thioether derivative
4 showed that it does not react with the c-MYC quadruplex in
the dark after 30 min, but yields the desired GQ monoadduct
upon irradiation (71 % conversion, Figure S17). The acetyl-
methionine derivative 5 presents even higher kinetic stability
than complex 4, and no traces of the metalation adducts, or
even of the aquo derivative 2, were observed after several
hours in the dark. However, irradiation for 30 min triggers
efficient covalent metalation of the GQ (Figure S20). We also
analyzed the effect of complex 5 on transcription of the c-
MYC gene by qRT-PCR in Hela cells. As shown in the
Figure 5 (left), c-MYC mRNA levels increased after irradi-
ation, becoming similar to those observed after treatment
with the aquo complex 2. Western-blot analysis confirmed
that enhancement of the gene expression only took place in
the presence of light, while the levels of the protein c-MYC
did not change when the cells were kept in the dark (Figure 5
and Figure S29). As expected, both qRT-PCR and western-
blot experiments showed that the aquo compound 2 is active
both in the dark and under irradiation. Moreover, control
experiments confirmed that the irradiation does not have any
measurable effect on cell viability (Figure S28), and that the
complex does not generate significant amounts of singlet
oxygen upon irradiation (Figure S25).
In conclusion, we have demonstrated the selective modi-
fication of accessible guanines flanking the GQ of c-MYC
with designed bulky ruthenium complexes. Importantly, the
bioorthogonal metalation enhances the expression of the
oncogene c-MYC. Given that an increase in c-MYC tran-
scription has been shown to be important in several cancers, in
particular for the renewal ability of cancer stem cells,[19] our
discovery might lead to interesting biological applications.
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of RNA synthesis). Amounts are relative to the expression levels of the
housekeeping gene GAPDH. Values are the average of three experi-
ments, and error bars indicate the standard error. B) Analysis of the
expression of c-MYC by western-blot. HeLa cells were incubated for
16 h with 100 mm compound 1 and then lysed, and c-MYC was
detected by SDS-PAGE, followed by western blot with an anti-MYC
Antibody (upper panel). The relative amount of protein in two
independent experiments was quantified by densitometry (lower
panel). Data are represented as the fold change with respect to
untreated controls. Error bars indicate the standard deviation of the
fold change with respect to untreated controls.
Figure 5. A) Thioether complexes 4 and 5. B) c-MYC transcription as
measured by qRT-PCR in the dark (black bars) or after irradiation
(60 min, light bars). Hela cells were incubated for 16 h with 100 mm
RuMet (5) or aquo complex 2. RNA levels are given relative to the
expression levels of the housekeeping gene GAPDH. C) Expression of
c-MYC as measured by western blot in the presence or absence of
compound 5. The relative amount of protein with respect to that of b-
actin was quantified by densitometry (lower panel). The experimental
procedures are as described in Figure 4.
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